Journal articleCancer Chemother Pharmacol2015
Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer.
- Journal
- Cancer Chemother Pharmacol
- Published
- 11 November 2015
- Citations
- 16
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Purpose We conducted a retrospective cohort study to examine whether neutropenia could be an indicator of good prognosis in patients treated with gemcitabine (GEM) for unresectable pancreatic cancer. Methods A total of 178 patients with unresectable pancreatic cancer, who were treated with first-line (n = 121) or second-line (n = 57) GEM, were included in our analyses. … Excerpt only: this text is the publisher’s. Read it in full at the source.